Noncontrast MRI out-of-pocket expenses vary quite a bit depending on geography and population.
Outpatient out-of-pocket costs for knee MRI vary considerably across the country, with lower prices in more populous areas, according to a study published in the Journal of the American College of Radiology.
Researchers from the Mayo Clinic in Rochester, MN, sought to determine the variability in pricing for noncontrast knee MRI, based on geographic location and population.
A total of 122 outpatient centers from 43 localities were included in the study. Nonhospital outpatient radiology centers were randomly chosen in each state’s highest-population locality, based on a list generated from the ACR MRI Accreditation Program database. The areas had to have at least two but no more than three centers for study inclusion. The data were further divided by population brackets: 50,000 to 500,000, 500,000 to 1 million, and more than 1 million.
The researchers, posing as a 21-year-old male college student who needed a noncontrast knee MRI to assess a knee injury sustained while playing football, contacted the centers by phone to determine the lowest, out-of-pocket, bundled cost (technical fee plus professional fee). The median (interquartile range) costs were calculated within each locality and region, including Midwest, Northeast, South, and West regions.
The results showed that costs for the examination ranged from $259 to $2,042 across all centers. For centers within a locality, the difference between the minimum and maximum costs ranged considerably among centers. For centers within a locality, the difference between the minimum and maximum costs among centers ranged from $1,592 to $0; median cost differences between localities ranged from $1,488 to $325.
Median cost geographically:
The researchers concluded that out-of-pocket expenses for outpatient knee MRIs varied considerably, both locally and nationally.
MRI or Ultrasound for Evaluating Pelvic Endometriosis?: Seven Takeaways from a New Literature Review
September 13th 2024While noting the strength of MRI for complete staging of disease and ultrasound’s ability to provide local disease characterization, the authors of a new literature review suggest the two modalities offer comparable results for diagnosing pelvic endometriosis.
Diffusion-Weighted MRI and Neoadjuvant Chemotherapy for Rectal Cancer: What New Research Reveals
September 3rd 2024In a comparison of imaging assessments to gauge the effectiveness of neoadjuvant chemotherapy for rectal adenocarcinoma, researchers found the combination of diffusion-weighted imaging and MR tumor regression grading had a 90 percent area under the curve (AUC) and a negative predictive value (NPV) of 93 percent.
FDA Expands Clearance of MRI-Guided AI Platform for Deep Brain Stimulation and Lesioning Techniques
September 3rd 2024Utilizing a new machine learning model, the OptimMRI software may improve radiosurgery applications and lesioning techniques such as MRI-guided focused ultrasound through enhanced targeting of the inferolateral part of the ventral intermediate nucleus (VIM).